Inappropriate Sinus Tachycardia, Postural Tachycardia Syndrome
Conditions
Keywords
Inappropriate Sinus Tachycardia, Postural Tachycardia Syndrome;, Sinus Node Sparing Hybrid Procedure
Brief summary
The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.
Interventions
DEVICEAtriCure Commercially Available Devices
Epicardial and endocardial hybrid ablation procedure used to treat the IST or POTS using AtriCure commercially available devices.
Sponsors
AtriCure, Inc.
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
1. Subject is scheduled to undergo or has undergone a procedure to treat IST or POTS using one or more AtriCure devices. 2. Subject is willing to provide written informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry) or authorization per institution and geographical requirements
Exclusion criteria
1. Subject is enrolled in a concurrent study that may impact treatment outcome of IST or POTS. 2. Subject with
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| AtriCure commercially available devices used to treat IST or POTS | 5 years | The IST Registry will attempt to enroll all eligible patients at registry sites who have already had or are scheduled to have a procedure to treat IST/POTS that includes the use of at least one commercially available AtriCure cardiac ablation devices. |
Countries
Belgium, Italy, Poland, United States
Contacts
CONTACTRegistry Specialist
Outcome results
None listed